SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Divis Laboratories
Divis Laboratories
BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 03, 17:00
1861.90
8.7 (0.47%)
VOLUME 1,513
LIVE
NSE
Jul 03, 17:00
1859.10
6.3 (0.34%)
VOLUME 61,143
News on Divis Laboratories
Select Year: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Indian Equities: Getting ready to Take-off, says Karvy

5.10 pm | 01 Jul 2015 |  Source: Moneycontrol.com

Karvy expects Nifty to trade in the band of 8400-10800 in the coming 12-15 months, implying a P/E band of 14-18x for CY16 consensus EPS. We remain ove...

Stay on long side in Divis Labs: Sudarshan Sukhani 

10.00 am | 18 Jun 2015 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends staying on the long side in Divis Labs....

Remain invested in Divis Lab, says Gaurang Shah 

4.23 pm | 12 Jun 2015 |  Source: CNBC-TV18

According to Gaurang Shah of Geojit BNP Paribas Financial Services, one may stay invested in Divis Laboratories....

Hold Divis Laboratories, SBI: Emkay

1.49 pm | 27 May 2015 |  Source: Moneycontrol.com

Emkay Global Financial Services has recommended to hold Divis Laboratories and State Bank of India (SBI) for the target price of Rs 1960 and Rs 308 re...

Stocks in news: ITC, SBI, Hero, Ipca, Natco Pharma, CEAT

8.10 am | 25 May 2015 |  Source: CNBC-TV18

ITC | SBI | MRPL | Hero Motocorp | Somany Ceramics | Henkel | NESCO | Divis Labs | Electrosteel Castings | CEAT | GHCL | Texmaco Rail | Natco Pharma |...

Divis Labs gains from sales surge, Q4 net up 18%

2.51 pm | 23 May 2015 |  Source: PTI

Consolidated total income from operations also rose to Rs 820.70 crore for the quarter under review against Rs 750.21 crore a year ago. For the full y...

Buy Divis Labs, Colgate Palmolive March Futs: ICICIdirect

2.55 pm | 16 Mar 2015 |  Source: Moneycontrol.com

ICICIdirect.com has recommended to buy Divis Laboratories March Future and Colgate Palmolive March Future for target of Rs 1970 and Rs 2280 respective...

Motilal Oswal neutral on Divis Laboratories

5.48 pm | 19 Feb 2015 |  Source: Moneycontrol.com

Motilal Oswal has maintained a 'Neutral' rating on Divis Laboratories with a target price of Rs 1910, in its research report dated January 31, 2015....

11 stocks you should keep an eye on: Emkay

3.53 pm | 11 Feb 2015 |  Source: Moneycontrol.com

Emkay has come out with its 11 stock picks report. The research firm has recommended to buy Jagran Prakashan, PVR, UPL, GSK Consumer; accumulate Shopp...

Buy Divis Labs; target of Rs 2050: ICICIdirect

3.53 pm | 15 Jan 2015 |  Source: Moneycontrol.com

ICICIdirect.com has recommended to buy Divis Laboratories in the range of Rs 1710-1735 for the target price of Rs 2050 with a stop loss of Rs 1556, in...

1 2
Quick Links for Divis Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.